Skip to main
CNC
CNC logo

Centene (CNC) Stock Forecast & Price Target

Centene (CNC) Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 6%
Buy 13%
Hold 69%
Sell 6%
Strong Sell 6%

Bulls say

Centene’s positive outlook is supported by its large membership base of 22 million medical members, primarily focusing on Medicaid, individual exchanges, and Medicare, indicating a strong foothold in government-sponsored healthcare plans. Recent positive data regarding Medicare Advantage (MA) and Medicare Part D (PDP) suggests potential earnings boosts for the second quarter of 2025, enhancing confidence in the company’s future performance amidst market fluctuations. Furthermore, despite the withdrawal of 2025 guidance due to higher-than-expected acuity increases, Centene's strategic adjustments, including a conservative trend in Medicaid, can help mitigate potential pressures, reinforcing its resilience in the competitive healthcare landscape.

Bears say

Centene faces significant headwinds with anticipated risk adjustments projected to be $1.8 billion to $2.75 billion lower than previously guided, indicating misalignment in revenue expectations. Furthermore, the company is grappling with ongoing pressures in Medicaid margin utilization and potential declines in marketplace risk scores, which could have adverse implications moving into 2026. Additionally, a notable 530 basis points miss in marketplace medical loss ratios (MLR) in the first quarter of 2025 has heightened investor caution, reflecting ongoing financial performance challenges.

Centene (CNC) has been analyzed by 16 analysts, with a consensus rating of Hold. 6% of analysts recommend a Strong Buy, 13% recommend Buy, 69% suggest Holding, 6% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Centene and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Centene (CNC) Forecast

Analysts have given Centene (CNC) a Hold based on their latest research and market trends.

According to 16 analysts, Centene (CNC) has a Hold consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $39.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $39.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Centene (CNC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.